1-Substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: Synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands

Archiv der Pharmazie

Volumn 331, Issue 5, 1998, Pages 163-169

  Matuszczak, Barbara ^a   Pekala, Elšbieta ^b   Müller, Christa E ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

4 chloropyrazolyl 1,2,4 triazolo 4,3 a quinoxalines; Adenosine receptors; Benzodiazepine; GABA(A) receptor; Structure activity relationships

Indexed keywords

1 BENZYL 4 [3(5) CHLORO 1H PYRAZOL 5(3) YL] [1,2,4]TRIAZOLO[4,3 A] QUINOXALINE; 4 [3(5) CHLORO 1H PYRAZOL 5(3) YL] 1 (2 FURYL) [1,2,4]TRIAZOLO[4,3 A]QUINOXALINE; 4 [3(5) CHLORO 1H PYRAZOL 5(3) YL] 1 (2 THIENYL) [1,2,4]TRIAZOLO[4,3 A] QUINOXALINE; 4 [3(5) CHLORO 1H PYRAZOL 5(3) YL] 1 (2 THIENYLMETHYL) [1,2,4]TRIAZOLO [4,3 A]QUINOXALINE; 4 [3(5) CHLORO 1H PYRAZOL 5(3) YL] 1 METHYL [1,2,4]TRIAZOLO[4,3 A] QUINOXALINE; 4 [3(5) CHLORO 1H PYRAZOL 5(3) YL] 1 PHENYL [1,2,4]TRIAZOLO[4,3 A] QUINOXALINE; 4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE RECEPTOR; BENZODIAZEPINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANXIETY NEUROSIS; ARTICLE; CONVULSION; DEPRESSION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; LIGANDS; PYRAZOLES; QUINOXALINES; RATS; RECEPTORS, GABA-A; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 0031863901     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199805)331:5<163::AID-ARDP163>3.0.CO;2-3     Document Type: Article

References (32)

1. G. Heinisch, B. Matuszczak, K. Mereiter, Heterocycles 1994, 38, 2081-2089.
2. a) B. Matuszczak, K. Mereiter, Heterocycles 1997, 45, 2449-2462;
3. b) B. Matuszczak, T, Langer, K. Mereiter, J. Heterocycl. Chem. 1998, 35, 113-115.
4. a) J.E. Francis, W.D. Cash, B.S. Barbaz, P.S. Bernard, R.A. Lovell, G.G. Mazzenga, R.C. Friedmann, J.L. Hyun, A.F. Braunwalder, P.S. Loo, D.A. Bennett, J. Med Chem. 1991, 34, 281-290;
5. b) D. Catarzi, L. Cecchi, V. Colotta, F. Melani, G. Filacchioni, C. Martini, L. Giusti, A. Lucacchini, J. Med. Chem. 1994, 37, 2846-2850;
6. c) W. Zhang, R. Liu, Q. Huang, P. Zhang, K.F. Koehler, B. Harris, P. Skolnick, J.M. Cook, Eur. J. Med. Chem. 1995, 30, 483-496;
7. d) J.D. Albright, D.B. Moran, W.B. Wright, Jr., J.B. Collins, B. Beer, A.S. Lippa, E.N. Greenblatt, J. Med. Chem. 1981, 24, 592-600.
8. a) J.E. Francis, W.D. Cash, S. Psychoyos, G. Ghai, P. Wenk, R.C. Friedmann, C. Atkins, V. Warren, P. Furness, J.L. Hyun, G.A. Stone, M. Desai, M. Williams, J. Med. Chem. 1988, 31, 1014-1020;
9. b) B.K. Trivedi, R.F. Bruns, J. Med. Chem. 1988, 31, 1011-1014;
10. c) R. Sarges, H.R. Howard, R.G. Browne, L.A. Lebel, P.A. Seymour, B.K. Koe, J. Med. Chem. 1990, 33, 2240-2254;
11. d) V. Colotta, L. Cecchi, D. Catarzi, G. Filacchioni, C. Martini, P. Tacchi, A. Lucacchini, Eur. J. Med. Chem. 1995, 30, 133-139.
12. a) T.A. Hamor, I.L. Martin in Progress in Medicinal Chemistry (Eds.: G.P. Ellis, G.B. West), Eisevier, 1983, 20, 157-223;
13. b) R.I. Fryer in Comprehensive Medicinal Chemistry (Eds.: C. Hansch, P.G. Sammes, J.B. Taylor, Vol.-Ed.: J.C. Emmett), Pergamon Press, 1990, 3, 539-566;
14. c) S.P. Gupta in Progress in Drug Research (Ed.: E. Jucker), Birkhäuser, 1995, 45, 67-106.
15. E.J. Jacobsen, R.E. TenBrink, L.S. Stelzer, K.L. Belonga, D.B. Carter, H.K. Im, W.B. Im, V.H. Sethy, A.M. Tang, P.P. von Voigtlander, J.D. Petke, J. Med. Chem. 1996, 59, 158-175.
16. a) P.J.M. van Galen, G.L. Stiles, G. Michaels, K.A. Jacobsen, Med. Res. Rev. 1992, 12, 423-471 and literature cited therein;
17. b) C.E: Müller, T. Scior, Pharm. Acta Helv. 1993, 68, 77-111;
18. a) C.E. Müller, B. Stein, Curr. Pharm. Design 1996, 2, 501-530 and literature cited therein;
19. b) C.E. Müller, Exp. Opin. Ther. Patents 1997, 7, 419-440 and literature cited therein;
20. c) P.G. Baraldi, B. Cacciari, G. Spalluto, A. Borioni, M. Viziano, S. Dionisotti, E. Ongini, Current Med. Chem. 1995, 2, 707-722.
21. U. Geis, K. Kiec-Konpnowicz, C.E. Müller, Sci. Pharm. 1996, 64, 383-390.
22. K.-N. Klotz, M.J. Lohse, U. Schwabe, G. Cristalli, S. Vittori, M. Grifantini, Naunyn-Schmiedeberg's Arch. Pharmacol. 1989, 340, 697-683.
23. C.E. Müller et al., unpublished results.
24. a) M.J. Dooley, R.J. Quinn, J. Med. Chem. 1992, 35, 211-216;
25. b) E. van der Wenden, A.P. IJzerman, W. Soudijn, J. Med. Chem. 1992, 35, 629-635;
26. c) M.J. Dooley, K. Motomichi, F. Suzuki, Bioorg. Med. Chem. 1996, 4, 923-934;
27. d) C.E Müller, U. Geis, B. Grahner, W. Lanzner, K. Eger, J. Med. Chem. 1996, 39, 2482-2491.
28. U. Geis, B. Grahner, M. Pawlowski, A. Drabczynska, M. Gorczyca, C.E. Müller, Pharmazie 1995, 50, 333-336.
29. Y. Cheng, W. Prusoff, Biochem. Pharmacol. 1973, 22, 3099-3108.
30. a) H. Möhler, T. Okada, Life Sci. 1977, 20, 2101-2110;
31. b) R.F. Squires, C. Braestrup, Nature 1977, 266, 732-734.
32. C.E. Müller, R. Sauer, U. Geis, F. Frobenius, P. Talik, M. Pawlowski, Arch. Pharm. Pharm. Med. Chem. 1997, 330, 181-189.